MyMD Pharmaceuticals, Inc. (MYMD) Financials

NASDAQ Currency in USD Disclaimer

$1.81

north_east NA Past Year
Day's range
$1.78
Day's range
$1.84
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning201720172018201820192019202020202021202120222022202320230%0%-200%-200%-400%-400%-600%-600%-800%-800%Profit Margin
Profit Margin
Revenue
Earnings

MYMD Income statement / Annual

Last year (2023), MyMD Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, MyMD Pharmaceuticals, Inc.'s net income was -$4.00 M. See MyMD Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $0.00 $0.00 $0.00 $1.58 M $1.67 M $3.93 M $2.96 M $2.12 M $4.43 M
Cost of Revenue $0.00 $0.00 $0.00 $29,452.00 $74,064.00 $1.54 M $1.42 M $1.08 M $950,792.00 $1.18 M
Gross Profit $0.00 $0.00 $0.00 -$29,452.00 $1.50 M $127,285.00 $2.51 M $1.88 M $1.16 M $3.25 M
Gross Profit Ratio 0 0 0 0 0.95 0.08 0.64 0.63 0.55 0.73
Research and Development Expenses $7.87 M $9.07 M $6.75 M $2.47 M $3.63 M $1.06 M $1.26 M $1.19 M $1.41 M $916,308.00
General & Administrative Expenses $5.44 M $6.22 M $21.46 M $5.81 M $5.76 M $5.67 M $4.08 M $3.01 M $4.03 M $3.98 M
Selling & Marketing Expenses $8.49 M $0.00 $0.00 $22,963.00 $238,036.00 $1.78 M $2.05 M $2.14 M $2.54 M $1.30 M
Selling, General & Administrative Expenses $8.49 M $6.22 M $21.46 M $5.81 M $3.32 M $7.45 M $6.13 M $5.15 M $6.57 M $5.28 M
Other Expenses -$762,830.00 $0.00 $0.00 $18,334.00 $40,008.00 $171,108.00 $171,108.00 $171,108.00 $236,706.00 $258,572.00
Operating Expenses $17.12 M $15.28 M $28.20 M $8.30 M $3.32 M $8.68 M $7.56 M $6.51 M $8.22 M $6.46 M
Cost And Expenses $17.12 M $15.28 M $28.20 M $8.30 M $3.40 M $10.22 M $8.98 M $7.59 M $9.17 M $7.63 M
Interest Income $0.00 $83,991.00 $8,907.00 $141.00 $101,483.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $608,460.00 $1.19 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $16.36 M $83,991.00 $617,367.00 $1.21 M $74,064.00 $234,486.00 $249,894.00 $286,162.00 $299,995.00 $349,398.00
EBITDA -$17.12 M $85,427.00 -$28.81 M -$8.28 M -$3.95 M -$10.06 M -$5.05 M $0.00 -$9.68 M -$2.78 M
EBITDA Ratio 0 0 0 0 -2.11 -6.37 -1.41 -1.02 -4.39 -0.63
Operating Income Ratio 0 0 0 0 -2.15 -5.14 -1.29 -1.56 -3.33 -0.72
Total Other Income/Expenses Net $13.12 M $85,427.00 -$1.08 M -$1.19 M $57,828.00 -$788,625.00 -$752,520.00 $25,102.00 $100,973.00 $76,954.00
Income Before Tax -$4.00 M -$15.20 M -$29.89 M -$9.49 M -$3.38 M -$10.85 M -$5.81 M -$3.30 M -$9.58 M -$3.13 M
Income Before Tax Ratio 0 0 0 0 -2.14 -6.51 -1.48 -1.12 -4.53 -0.71
Income Tax Expense $4.22 M -$85,427.00 -$8,907.00 $1.19 M -$83,650.00 -$2.29 M -$752,520.00 $1.32 M -$269,344.00 $15,793.00
Net Income -$4.00 M -$15.11 M -$29.88 M -$10.68 M -$3.89 M -$10.85 M -$5.81 M -$3.30 M -$9.31 M -$3.13 M
Net Income Ratio 0 0 0 0 -2.47 -6.51 -1.48 -1.12 -4.4 -0.71
EPS -2.59 -11.68 -25.6 -90.86 -380.79 -23.73 -117.39 -116.81 -347.78 -126.52
EPS Diluted -2.59 -11.68 -25.6 -90.86 -380.79 -23.73 -117.39 -116.81 -347.78 -126.52
Weighted Average Shares Out $1.54 M $1.29 M $1.17 M $117,544.00 $10,211.00 $457,246.00 $49,453.00 $28,282.00 $26,775.00 $24,717.00
Weighted Average Shares Out Diluted $1.54 M $1.29 M $1.17 M $117,544.00 $10,211.00 $457,246.00 $49,453.00 $28,282.00 $26,775.00 $24,717.00
Link